Patrick Y. Yang - 21 Mar 2022 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role: Director
Signature: s/ James J. MacDonald, Attorney-in-Fact for Patrick Y. Yang
Issuer symbol: SANA
Transactions as of: 21 Mar 2022
Transactions value $: $204,400
Form type: 4
Filing time: 22 Mar 2022, 19:51:00 UTC
Previous filing: 16 Mar 2022
Next filing: 08 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SANA	Common Stock	Purchase	$204,400	+28,000	+19.15%	$7.3	174,250	21 Mar 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.14 to $7.40, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.14 to $7.40, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.